Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Plasma cell 1Other hematologic neoplasm 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Lung Neoplasms 1Disease 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × In Situ Hybridization × Thoracic × Clear all
NCT05707585 2023-02-01

Lung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar Lavage

The Second Affiliated Hospital of Dalian Medical University

Unknown
2,064 enrolled
Thoracic

Disease, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡